The Valley Desk

NCT06844383 · Interventional trial

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

Overall registry status Recruiting

Phase 2

Conditions Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov